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SUMMARY 26
In this study a novel method to determine iodine concentrations in human breast milk 27 was developed and validated. The iodine was analyzed by inductively coupled plasma 28 mass spectrometry (ICPMS) following tetramethylammonium hydroxide (TMAH) 29 extraction at 90 o C in disposable polypropylene tubes. While similar approaches have 30 been used previously, this method adopted a shorter extraction time (1 hour vs. 3 hours) 31 and used Antimony (Sb) as the internal standard, which exhibited greater stability in 32 breast milk and milk powder matrices compared to Tellurium (Te). Method validation 33 included: defining iodine linearity up to 200µg L -1 ; confirming recovery of iodine from 34 NIST 1549 milk powder. A recovery of 94 -98 % was also achieved for the NIST 1549 35 milk powder and human breast milk samples spiked with sodium iodide and thyroxine 36 (T4) solutions. The method quantitation limit (MQL) for human breast milk was 1.6 µg 37 L -1 . The intra -assay and inter -assay coefficient of variation for the breast milk 38 samples and NIST powder were <1% and <3.5% respectively. NIST 1549 milk powder, 39
49

INTRODUCTION 50
Iodine is a major constituent of thyroid hormones, and an adequate supply of iodine 51 before birth and in early infancy is essential for achieving optimal physical growth and 52 mental development [1] . Breast milk is the sole source of iodine for exclusively breast-53 fed infants, and it is therefore critical to ensure that the iodine content of the breast milk 54 is sufficient to meet the nutritional needs of this infant population. However, relatively 55 few studies have reported breast milk iodine concentrations, and this is largely due to 56 the lack of a robustly validated method for assessing iodine concentrations in human 57 breast milk. 58
Since breast milk is a complex matrix, consisting of a range of bioactive components 59 and nutrients, existing studies which have measured iodine concentrations in breast milk 60 have applied comparable methods to those used for assessing iodine content of food. and these 2 standards in turn were used to make the calibration solutions in 1% TMAH. 154 1 mL of internal standard solution was added to 40 mL of each these iodine calibration 155
solutions. The calibration solutions were stored at room temperature and fresh solutions 156 prepared every 4 months. 157
Iodine drift correction standard solutions (0 and 5 µg L -1 ). The iodine intermediate 158 standard 2 solution (0.05 mg L -1 ) was used to make the drift correction standard. Both 159 these standards were prepared in 1% TMAH. 1 mL of internal standard solution was 160 added into 40 mL of each these iodine drift correction standard solutions. 161
Blanks. Four types of blanks were used; a calibration blank, a method digestion blank 162 processed in exactly the same way as the samples and containing all the reagents used in 163 the assay, a drift correction blank and a system blank. All blanks were prepared in 1% 164 TMAH and also contained the internal standard mix. The calibration blank was used to 165 establish the analytical calibration curve, the method digestion blank was used to 166 account for batch to batch variation and to overcome system memory effects from the 167 instrument by subtraction during result calculation, the drift correction blank was used 168 to normalize the drift standard solution every 25 samples during each analytical run and 169 the system blank was used to monitor the overall system memory from the instrument 170 during each analytical run. 171
Wash solutions. Three types of wash solutions were used. Two of the solutions, the 172 auto-sampler wash station rinse solution and an extra clean wash solution, consisted of 173 1% TMAH and high purity water. Another pre -wash solution was prepared with 1% 174 ammonia (NH 4 ) in high purity water. 175
176
Instrumentation 177
Iodine determination was carried out using an Agilent7500ce ICPMS system consisting 178 of an Integrated Sample Introduction System (ISIS) unit plus a CETAC ASX-510 auto-179 sampler (Agilent Technologies Australia) equipped with a Ceramic VeeSpray nebulizer 180 (Glass Expansion Pty. Ltd, Melbourne, Australia). The ISIS peristaltic pump program 181 was used to reduce the washout time and speed up sample uptake to the instrument 182 between samples to reduce analysis time per sample. Instrument performance 183 optimization, including nebulizer gas flow rate, ion lens voltage and torch alignment, 184 was set up following the manufacturer's instructions and optimized before each run. 185
Operating conditions for the systems are shown in Table 1 . 186
All raw concentration data from the ICPMS was exported to Microsoft Excel. Blank 187 subtraction, drift correction and other data processing (mass and volume adjustments) 188 were performed off -line, using custom -written macro programs operated within 189 cleaning efficiency of the 1% NH 4 pre -wash solution was also tested on a highly 228 contaminated system. Furthermore, the clean -up efficiency of the pre -wash solution 229 was monitored in each analytical run by collecting iodine concentrations of all the blank 230 solutions defined above to assess the instrument memory effect. 231
Sample -to -sample carryover 232
Previous studies in our group had indicated that 4 % perchloric acid digests and high 233 salt matrices had the potential to cause precipitation within a range of nebulizers leading 234 to significant drift throughout long analytical runs. These studies also suggested the use 235 of wet argon in the nebulization gas could prevent significant drift and reduce sample -236 to -sample carry over. In the present study, sample carryover from a previous analytical 237 sample was determined after washing the nebulizer with either dry or wet argon. 238
The sample carryover in these tests was determined by assessing iodine concentration in 239 15 successive replicate blanks following the measurement of iodine in a highly 240
Three of the iodine standard solutions (2.5, 5 and 10µg L -1 ) were analyzed on repeated 243 occasions over a 2.5 month period to assess the stability of iodine standards during 244 storage. The iodine concentrations measured at each of the time points across the 2.5 245 month period were compared to those in the equivalent standard immediately after 246 preparation. 247
248
Stability and reliability of internal standards 249
The stability and reliability of two internal standards, Sb and Te, were tested in the 250 human breast milk matrix in order to assess their suitability for routine analysis. Human 251 breast milk samples, NIST non -fat milk powder reference material and standards were 252 prepared as described earlier with the addition of a mixture of 2 internal standards (Sb 253 and Te). The raw counts of iodine (I), Sb and Te were monitored to check for stability. 254
The raw I counts were also normalized to both the raw Sb and Te counts to evaluate the 255 stability and reliability of each internal standard across the analytical run. 256
Human breast milk homogeneity 257
After collection, the breast milk sample was mixed by shaking vigorously, split into 2 258 aliquots and then frozen at -20°C until analysis. After thawing, one aliquot was 259 homogenized at 20,000 min -1 for 30 seconds while in the other the milk was allow to 260 separate into two phases, the aqueous and fatty fractions. The iodine level of each 261 fraction was measured and compared to the concentration measured in the homogenized 262 sample. 263
265
Stability of extracted samples 266
To assess the stability of iodine in samples post -digestion, NIST 1549 milk powder 267 and 2 human milk samples were digested by using the digestion procedure described 268 above and iodine levels measured on the day of digestion and following 2.5 months 269 storage at room temperature. 270
Contamination check of components used in the milk collection and analysis 271
A small amount of high purity water was placed into the various containers and devices 272 used in the milk collection process. This included 2 types of collection containers, 2 273 types of breast pump systems and 2 types of storage tubes. The water was left to 274 stabilize for periods varying from 3 hours to 2.5 weeks. Samples of this high purity 275
water were then collected and tested for iodine contamination using the same method as 276 for human milk samples. The contamination check was also conducted for all the 277 disposable PP tubes used in the digestion and analysis steps. 
Method Optimization 320
Optimal digestion time and temperature for iodine extraction from human breast milk 321
It was critical to achieve a complete sample digestion to ensure the accuracy of iodine 322 measurements conducted in downstream applications, including ICPMS. As illustrated 323
in Table 2 the efficiency of extraction of iodine from human breast milk was similar 324 under all tested conditions. The extraction efficiency for the NIST CRM 1549 milk 325 powder also showed good agreement with the certified value (3.38±0.02 mg kg -1 ) for all 326 3 processes tested. We chose to use a digestion temperature of 90 0 C for 1 hour for all 327 subsequent experiments to reduce the overall time required for sample preparation. 328
Instrument/system memory effect 329
We found 2 significant areas within the ICPMS that showed memory effect; the auto-330 sampler wash station and the uptake tubing/nebuliser/spray chamber area. There was a 331 marked difference in the time taken for the background counts to drop to acceptable 332 levels between the 1% TMAH and 1% NH 4 pre -wash solutions. When using 1% 333 TMAH to wash out the the 2 areas identified above, the background count levels 334 decreased gradually and often did not reach an acceptable level even after ~ 2 -3 hours 335 from the start of the wash procedure or well into the actual analysis run. In contrast,using a 1% NH 4 solution resulted in a sharp drop in the background counts to an 337 acceptable level after only 10 minutes in the uptake area. The auto -sampler wash 338 station also required extra soaking with 1% NH 4 to remove long term buildup (data not 339 shown). 340
The data presented in Figure 1 supports these findings. . In the clean system, achieved 341 after 1 day of running routine breast milk iodine analyses, the iodine concentration in 342 the blank decreased only slightly at the start of the run before stabilizing, indicating that 343 there was minimal iodine contamination prior to the start of the run. In contrast, in both 344 the highly contaminated and slightly contaminated systems, the iodine concentrations in 345 the blank solutions analyzed after the pre-wash with 1% TMAH dropped sharply at the 346 beginning of the analysis run before declining to acceptable iodine levels for the blank 347 sample, indicating that 1% TMAH wash -out was not effective at reducing the iodine 348 concentrations to acceptable levels prior to the analytical run. In the highly 349 contaminated system cleaned using the 1% NH4 pre -wash solution, however, we 350 achieved a similar washout profile to the clean system washed with 1% TMAH. This 351 suggested that a 1% NH 4 pre -wash solution could be used once before each run to 352 achieve an acceptable background count at the beginning of the analytical run. 353 We also observed a substantial and variable drop in the baseline counts depending upon 354 the extent of the system contamination, indicating that the way the method digestion 355 blank is handled is critical with respect to the calculation of the final results. We 356 therefore subtracted our method digestion blank value from each batch of samples as a 357
part of calculation. 358
Sample -to -sample carryover 359 Figure 2 shows the result of the sample carryover experiment comparing the extent of 360 carryover after using either wet or dry argon to rinse the nebulizer between samples.wet and dry argon in this system. 363
Stability of the iodine calibration standards 364
Over the 2.5 month period, the percentage error for the measurement of the 3 iodine 365 calibration solutions ranged from -1.3 to +0.5% with respect to their actual 366 concentration. Iodine standard solutions appeared to be very stable after preparation for 367 a period of at least 6 months (data not shown). 368
Stability and reliability of internal standards 369
As expected with ICPMS the raw count stability over the various runs varied 370 significantly for both internal standards as well as iodine (data not shown). When the 371 raw iodine counts were normalized to the raw counts for the 2 internal standards in the 372 drift check standard, the stability for iodine concentration measured across the run 373 improved significantly for both Sb and Te. When Sb was used the internal standard, the 374 values for the NIST milk powder certified reference material were consistent with the 375 expected value. However, when the iodine counts were normalized to the Te standard 376 counts, the calculated result for the NIST milk powder certified reference material 377 exceeded the expected value by 10% of the expected value. Sb was therefore selected as 378 the internal standard used to correct for the variability caused by matrix effects and 379 instrument drift in this assay. 380
Human breast milk homogeneity 381
The iodine level in the fatty fraction (145 ± 48 µg L -1 ) was considerably higher and 382 more variable than in the aqueous fraction (88.5 ± 2.1 µg L -1 ). The iodine concentration 383 in the homogenized samples (105.7 ± 0.6 µg L -1 ) were notably less variable, and were 384 intermediate to that of the two separate fractions. These iodine concentrations werewithin the expected range of breast milk iodine levels in breast-feeding women from 386 iodine sufficient populations(unpublished data). 387
Stability of extracted samples 388
There was no difference in the iodine concentration measured in digested samples 389 immediately after digestion or after 2.5 months of storage post-digestion (Table 3) . 390
Contamination check of components used in milk collection and analysis. The results obtained for the NIST milk standard using this method was 3.38 ± 0.02 mg 414 kg -1 (N = 78) was in a close agreement with the certified value of 3.38 ± 0.02mg kg -1 . 415
The RSD was 0.5 % with a 95 % CI of 0.005. 416
Detection limits 417
The IDL for iodine in human milk was 0.013 µg L -1 if carryover and contamination 418 were eliminated as described in this paper. Assuming a dilution factor of 40, the MQL 419 and herb milk [28] , but this is the first report of its successful application in the 452 assessment of iodine in human breast milk samples. In addition, we showed that we 453 were able to obtain complete and reproducible digestion with considerably shorter 454 heating times compared to previous studies (1 hour vs 2-3 hours) [7, 13, 16] thus 455 reducing the total time required for the experimental procedure. 456 be extracted by TMAH, there had been no reports of successful extraction of iodine 459 from iodine -containing compounds, such as T4. The failure to liberate iodine from 460 such compounds during the digestion process would result in underestimation of the 461 iodine content of the sample, thus impacting on accuracy and reliability of the 462 measurements. By assessing the recovery of iodine from human breast milk samples 463 spiked with T4 in the present study, we confirmed that TMAH digestion was able to 464 release iodine from this complex, and therefore provide an accurate measure of the total 465 iodine content of the sample. 466
467
We did not find any difference between wet and dry argon in the efficacy of reducing 468 carryover between samples in this study. Although not the focus of our study, flushing 469 the system with wet argon is likely to be preferable in practice, since it is able to prevent 470 the build of iodine contamination within the argon jet in the nebulizer, which has the 471 potential to introduce random errors during large analytical runs (unpublished data). We 472 identified the auto -sampler wash station as a major source of instrument carryover 473 when the ICPMS machine had previously been utilized for the assessment of other 474 elements and using other wash out solutions (e.g. nitric acid solutions). Thus, 475 thoroughly flushing the system with a 1% NH 4 solution prior to commencing any new 476 assay is necessary to avoid carryover effects due to previous analyses conducted on the 477 same instrument. reduces the cost and reading time in routine analysis. It was also noted that the largest 488 difference between successive drift iodine levels occurred at the beginning of the run 489 and this also needed to be taken into account during the drift correction to achieve the 490 most accurate results. 491
492
Te has commonly been used as an internal standard in ICPMS methods and was 493 selected due to the fact that its ionization status is closer to iodine than other elements 494
[13]. However, the Te signal in the milk powder experiment was lower and more 495 variable than expected, resulting in reduced accuracy in the assessment of iodine 496
concentrations. This may be because Te precipitates with some components within the 497 human milk matrix, and indicates that it is not the most appropriate internal standard for 498 this method. However, Sb exhibited much greater stability in the human milk matrix in 499 the present study and appears to be a more suitable internal standard for ICPMS 500 assessment of human breast milk. 501
502
In a previous study reporting the analysis of iodine in food, high-cost tubes were used 503 during sample digestion, which were washed and re-used for subsequent assays. Even 504 with thorough washing, there is the potential for trace amounts of iodine to remain in 505 the tubes, which could produce carryover effects and introduce inaccuracies in the 506 results [13] . In this method, we eliminated this source of contamination by using 507 disposal screw cap polypropylene tubes [30] . Disposable auto -sampler tubes and 508 pipette tips were also used to minimize the potential for contamination. Importantly, we 509 confirmed that all the containers and equipment that were in contact with the sample at 510 any stage in the process of collection, processing and analysis were free from iodine 511 contamination, and can thus be confident that any iodine detected in this assay 512 originated from the breast milk sample. Confirming the absence of contamination is 513 critical to ensuring that the results of the assay are a true reflection of concentrations in 514 the sample and should be standard practice in any application of this method. 515 516 Appropriate sample preparation is essential to achieve reliable results. Despite the fact 517 that human milk is known to separate into 2 distinct layers after thawing or during 518 extended periods of standing, no previous method has provided detailed information 519 regarding sample preparation. This study confirmed that iodine concentration differs 520 markedly between the fatty and aqueous fractions of human milk and that complete 521 homogenization of the samples is required prior to digestion in order to obtain reliable 522 results. 523
The stability of extracted human milk samples had not been tested in previous methods. 524
In this modified method we found that iodine level in extracted human milk also 525 containing the internal standard was stable for at least 2.5 months when stored at room 526 temperature. The finding increases the potential for this method to be utilized in large-527 scale clinical trials and population screening programs, since it makes it possible for 528 samples collected at different times to be analyzed in the same ICPMS run.
In conclusion, we have successfully validated a method for the assessment of iodine in 531 human breast milk which overcomes the limitations of previous approaches and highly 532 accurate, reproducible and precise. The modified method is able to recover over 95% of 533 iodine from spiked solutions, has a lower quantitation limit than previous method and 534 has inter -and intra -assay coefficients of variation well below 5%. This method 535 represents a significant advance in the assessment of iodine concentrations in human 536 breast milk and its application will enable us to gain new insights into the iodine status 537 of lactating women. This assay is currently being applied for routine assessment of 538 iodine concentration in breast milk samples in our laboratory. blank (0µg L -1 ) over the course of an ICPMS run at 3 levels of system contamination; 648 Contaminated system after 1% TMAH pre -wash solution ( ), slightly contaminated 649 system after 1% TMAH pre -wash solution ( ) and clean system after 1% TMAH pre 650 -wash solution ( ), contaminated system after 1% NH 4 pre -wash solution ( ). 651
The iodine concentration at t=0 represents the iodine calibration blank concentration. 652
The negative iodine concentrations indicate the extent of wash -out during each 653 analytical run. 654 
